New Hampton, New York. July 23, 2018. Balchem Corporation (NASDAQ: BCPC), the global leader in choline and precision release nutrient technologies, recently announced the addition of three new team members and five promotions within the Animal Nutrition and Health segment.
“As Balchem continues to strategically expand our ruminant and monogastric portfolios globally, we look to current and new staff for forward-thinking and success-driven individuals to assist in that growth,” notes Jonathan Griffin, Vice President and General Manager of Balchem Animal Nutrition and Health. “These promotions and additions to the team will allow us to deliver more knowledge, focus and expertise to our current and new customers.”
Stephanie Cocchiara joins Balchem as Marketing Specialist. She comes to Balchem from a consumer products company and will be responsible for digital and social media strategies, event management and domestic marketing program implementation. Cocchiara received her Bachelor of Science degree in Business Administration in Marketing from the University of Hartford.
Greta Stridsberg joins as a Regional Sales Specialist, covering Ohio, Indiana and Michigan. She began her career at Balchem as an intern and now joins the sales team. Stridsberg’s knowledge and background in the dairy industry is vital as she works closely with key dairies, nutritionists and Balchem customers. She holds a Bachelor of Science degree in Agriculture from The Ohio State University.
Jon Rentschlernow serves as Balchem’s Regional Sales Specialist, covering Texas, New Mexico, Oklahoma and Southwest Kansas. Previously employed at Monsanto as a District Manager, Rentschler will continue working closely with customers to deliver practical business solutions.
Eileen Frangione is promoted to Regional Sales Specialist. Previously serving as Customer Service Manager and Marketing Communications Manager, she will now fill the sales position in Eastern New York and New England. Frangione will work directly with nutritionists, dairy producers, veterinarians and channel partners.
Job van Gunsteren is now the Director of EMEA Region and Animal Nutrition and Health Global Strategy. He will continue to maintain the lead position in the European feed choline market, while also furthering growth in KeyShure and the encapsulated product portfolio.
Luke Lines fills the role of Regional Development Manager, East. In this position, he will provide training and strategic direction to other sales professionals while maintaining his commitment to select nutritionists and customers.
Dr. Jeff Elliott expands his position at Balchem and now serves as Technical Service Specialist, Strategic Accounts. In this newly created position, he will support the ruminant and monogastric sales teams and focus on providing support to global market partners. Previously, Dr. Elliott was Global Business Manager for the Animal Nutrition and Health minerals platform.
Fred Sciulli is promoted to Global Business Manager, Minerals and will focus on identifying market needs and developing the minerals portfolios to address those challenges. Sciulli previously served as Manager of Financial Planning and Analysis.
Balchem Corporation reports four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.
This release contains forward-looking statements, which reflect Balchem’s expectation or belief concerning future events that involve risks and uncertainties. Balchem can give no assurance that the expectations reflected in forward-looking statements will prove correct and various factors could cause results to differ materially from Balchem’s expectations, including risks and factors identified in Balchem’s annual report on Form 10-K for the year ended December 31, 2016. Forward-looking statements are qualified in their entirety by the above cautionary statement. Balchem assumes no duty to update its outlook or other forward-looking statements as of any future date.